EHMT2-IN-1
|
E646651-10mg
|
|
2230849-55-3 |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Edasalonexent
|
E646583-5mg
|
≥98% |
1204317-86-1 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Edasalonexent
|
E646583-50mg
|
≥98% |
1204317-86-1 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
Edasalonexent
|
E646583-25mg
|
≥98% |
1204317-86-1 |
25mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
Edasalonexent
|
E646583-10mg
|
≥98% |
1204317-86-1 |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Edasalonexent
|
E646583-100mg
|
≥98% |
1204317-86-1 |
100mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
Epertinib
|
E646582-1mg
|
|
908305-13-5 |
1mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
EPI-743
|
E646581-5mg
|
≥98% |
1213269-98-7 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
EPI-743
|
E646581-50mg
|
≥98% |
1213269-98-7 |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
EPI-743
|
E646581-25mg
|
≥98% |
1213269-98-7 |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
EPI-743
|
E646581-10mg
|
≥98% |
1213269-98-7 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
eIF4A3-IN-16
|
E646542-1mg
|
|
1402931-74-1 |
1mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
(S)-ErSO
|
E646526-5mg
|
≥99% |
2407860-34-6 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
(S)-ErSO
|
E646526-25mg
|
≥99% |
2407860-34-6 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
(S)-ErSO
|
E646526-10mg
|
≥99% |
2407860-34-6 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Eltoprazine hydrochloride
|
E646502-5mg
|
≥99% |
98206-09-8 |
5mg
|
¥ 650.9
|
期货,请咨询 |
阿拉丁 |
Eltoprazine hydrochloride
|
E646502-50mg
|
≥99% |
98206-09-8 |
50mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Eltoprazine hydrochloride
|
E646502-25mg
|
≥99% |
98206-09-8 |
25mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
Eltoprazine hydrochloride
|
E646502-10mg
|
≥99% |
98206-09-8 |
10mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
Eltoprazine hydrochloride
|
E646502-100mg
|
≥99% |
98206-09-8 |
100mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
(Rac)-Etavopivat
|
E646466-5mg
|
≥99% |
2622070-93-1 |
5mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
(Rac)-Etavopivat
|
E646466-10mg
|
≥99% |
2622070-93-1 |
10mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
EPZ-719
|
E646460-5mg
|
≥99% |
2697176-16-0 |
5mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
EPZ-719
|
E646460-10mg
|
≥99% |
2697176-16-0 |
10mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |